Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 951-974-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2012-09-28 to 2012-12-01
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
- Report date:
- 2013
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- 31 May 2008
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- adopted July 21, 1997
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- 1-Propanaminium, 2-hydroxy-N-(2-hydroxypropyl)-N,N-dimethyl-, esters with fatty acids, C16-18 (even numbered) and C18 unsatd., Me sulfates (salts)
- Cas Number:
- 1079184-43-2
- Molecular formula:
- n.a. (UVCB)
- IUPAC Name:
- 1-Propanaminium, 2-hydroxy-N-(2-hydroxypropyl)-N,N-dimethyl-, esters with fatty acids, C16-18 (even numbered) and C18 unsatd., Me sulfates (salts)
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- - Name of test material (as cited in study report): HH-2012-414 solid
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- other: NMRI BR
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River, Sulzfeld, Germany
- Age at study initiation: 6 weeks
- Weight at study initiation: males 33.9 ± 1.9 g, females 28.7 ± 2.0 g
- Assigned to test groups randomly: yes
- Fasting period before study:
- Housing: in groups (maximum 5 animals per sex per cage) in Macrolon cages (type MIII height: 15 cm) containing sterilised sawdust as bedding material
- Diet (e.g. ad libitum): pelleted rodent diet, ad libitum
- Water (e.g. ad libitum): tap water, ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20.6 - 21.5°C
- Humidity (%): 38 - 66%
- Air changes (per hr): app. 15/h
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil
- Justification for choice of solvent/vehicle: not given - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
prepared on the day of administration
- dosing volume: 10 mL/kg bw - Duration of treatment / exposure:
- 24 h
- Frequency of treatment:
- 1x
- Post exposure period:
- 24 h (+48 h for 2000 mg/kg bw dose group)
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 500, 1000, 2000 mg/kg bw
Basis:
- No. of animals per sex per dose:
- 5 (main test)
3 (pretest) - Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide
- Route of administration: intraperitoneal injection
- Doses / concentrations: 40 mg/kg bw
Examinations
- Tissues and cell types examined:
- bone marrow
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: based on results of a dose range finding test
DETAILS OF SLIDE PREPARATION:
- bone marrow was flushed from femurs with approximately 2 mL of fetal calf serum
- cell suspension was collected and centrifuged at 216 g for 5 min
- supernatant was removed with a Pasteur pipette leaving one drop of serum on the pellet, cells were mixed with the remaining serum
- a drop of the cell suspension was placed on the end of a clean slide, which was previously immersed in a 1:1 mixture of 96% (v/v) ethanol and cleaned with a tissue
- the drop was spread by moving a clean slide with round-whetted sides at an angle of approximately 45° over the slide with the drop of bone marrow suspension; the preparations were air-dried, fixed for 5 min in 100% methanol and air-dried overnight
- two slides were prepared per animal
- staining with Giemsa
METHOD OF ANALYSIS:
- slides were scored at a magnification of 1000 x
- the number of micronucleated polychromatic erythrocytes was counted in at least 2000 polychromatic erythrocytes (with a maximum deviation of 5%)
- the ratio of polychromatic to normochromatic erythrocytes was determined by counting and differentiating the first 1000 erythrocytes at the same time
- micronuclei were only counted in polychromatic erythrocytes
- averages and standard deviations were calculated - Evaluation criteria:
- A micronucleus test is considered acceptable if it meets the following criteria:
- The incidence of micronucleated polychromatic erythrocytes in the positive control animals should be above the historical control data range.
- The positive control substance induced a statistically significant (Wilcoxon Rank Sum Test, one-sided, p < 0.05) increase in the frequency of micronucleated polychromatic erythrocytes.
- The incidence of micronucleated polychromatic erythrocytes in the control animals should reasonably be within the laboratory historical control data range.
A test substance is considered positive in the micronucleus test if:
- It induced a biologically as well as a statistically significant (Wilcoxon Rank Sum Test, one-sided, p < 0.05) increase in the frequency of micronucleated polychromatic erythrocytes (at any dose or at any sampling time) in the combined data for both sexes or in the data for male or female groups separately and the number of micronucleated polychromatic erythrocytes in the animals are above the historical control data range.
A test substance is considered negative in the micronucleus test if:
- None of the tested concentrations or sampling times showed a statistically significant (Wilcoxon Rank Sum Test, one-sided, p < 0.05) increase in the incidence of micronucleated polychromatic erythrocytes either in the combined data for both sexes or in the data for male or female groups separately and the number of micronucleated polychromatic erythrocytes in the animals are within the historical control data range - Statistics:
- Wilcoxon Rank Sum Test, one-sided, p < 0.05
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: 2000 mg/kg bw
- Clinical signs of toxicity in test animals: hunched posture, rough coat, lethargy
RESULTS OF DEFINITIVE STUDY
- animals of the negative and positive control groups showed no treatment related clinical signs of toxicity or mortality
- 1000 and 2000 mg/kg bw: hunched posture, rough coat, lethargy
- 500 mg/kg bw: hunched posture, rough coat
- Induction of micronuclei (for Micronucleus assay): no increase in the mean frequency of micronucleated polychromatic erythrocytes was observed
- Ratio of PCE/NCE (for Micronucleus assay): no decrease in the ratio of polychromatic to normochromatic erythrocytes, which indicated a lack of toxic effects of this test substance on the erythropoiesis
- Appropriateness of dose levels and route:
tested up to maximum recommended dose in accordance with current regulatory guidelines
route of administration (intraperinoneal) was chosen to maximize the chance of the test substance reaching the target tissue
Any other information on results incl. tables
Treatment mg/kg bw |
Sampling time [h] |
Number of micronucleated polychromatic erythrocytes (mean ± SD) |
Ratio polychromatic/ normochromatic erythrocytes (mean ± SD) |
males |
|||
0 (vehicle) |
24 |
2.2 ±1.3 |
0.95 ±0.06 |
2000 |
24 |
2.0 ±0.7 |
0.68 ±0.31 |
2000 |
48 |
1.2 ±0.4 |
0.70 ±0.20 |
1000 |
24 |
2.0 ±1.4 |
0.69 ±0.15 |
500 |
24 |
2.2 ±1.3 |
0.81 ±0.13 |
Cyclophosphamide, 40 mg/kg bw |
48 |
25.4 ± 4.2* |
0.47 ±0.22 |
females |
|||
0 (vehicle) |
24 |
1.8 ±0.8 |
0.96 ±0.06 |
2000 |
24 |
2.8 ±1.1 |
0.78 ±0.22 |
2000 |
48 |
0.4 ±0.5 |
0.79 ±0.14 |
1000 |
24 |
2.8 ±1.1 |
0.84 ±0.10 |
500 |
24 |
1.4 ±0.9 |
0.81 ±0.15 |
Cyclophosphamide, 40 mg/kg bw |
48 |
22.8 ± 5.0* |
0.62 ±0.12 |
* Significantly different from corresponding control group (Wilcoxon Rank Sum Test, P = 0.01).
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
MDEA-Esterquat C16-18 and C18 unsatd. was evaluated for clastogenic potential in the NMRI BR mouse bone marrow micronucleus assay at doses of 0, 500, 1000 and 2000 mg/kg bw. Under the conditions of the study, the test substance did not induce an increase in the frequency of micronucleated polychromatic erythrocytes in bone marrow after any treatment time. - Executive summary:
In a NMRI BR mouse bone marrow micronucleus assay according to OECD guideline 474 (adopted July 21, 1997) and EU method B.12 (31 May 2008) 5 animals/sex/dose were treated by intraperitoneal injection with MDEA-Esterquat C16-18 and C18 unsatd. at doses of 0, 500, 1000 and 2000 mg/kg bw. Bone marrow cells were harvested at 24 h for all dose levels and additionally at 48 h at 2000 mg/kg bw post-treatment. The vehicle was corn oil.
Hunched posture, rough coat and lethargy were observed at 1000 and 2000 mg/kg bw; hunched posture and rough coat were also present at 500 mg/kg bw.
MDEA-Esterquat C16-18 and C18 unsatd. was tested up to the maximum recommended dose in accordance with current regulatory guidelines. No decrease in the ratio of polychromatic to normochromatic erythrocytes, which indicated a lack of toxic effects of this test substance on the erythropoiesis. However the route of exposure was chosen to maximise the chance of the test substance reaching the target tissue.
The positive control induced the appropriate response.
There was no significant increase in the frequency of micronucleated polychromatic erythrocytes in bone marrow after any treatment time.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.